ARCHIVES

NIH institute directors, in response to question from Sen. Arlen Specter, say Bush Administration’s stem cell research policy is harmful to NIH leadership in science.

This article is from The Cancer Letter archive.

Vol. 31 No. 14 | April 8, 2005

Download PDF Visit The Full Archive

Related Articles

Blumenthal Names Presidential Advisor; Groups Lobby To Limit Her Influence

October 3, 1997

ODAC Rejects Amsacrine NDA, Renews Idarubicin

September 14, 1990

FCRF Contracts Hit $40.3 Million With Transfer Of Labs From NIH, Elsewhere

October 8, 1982

Consensus Panel Determines Total Mastectomy Plus Node Dissection “Satisfactory Alternative” To Radical Mastectomy

June 15, 1979

NIH Makes Changes To Area Grants

April 25, 1997

Berlin, DeVita Differ On Use Of L-PAM

November 8, 1974